HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Leon W.M.M. Terstappen, MD, Ph.D., Chief Scientific Officer of Immunicon Corporation (NASDAQ-GM:IMMC) will chair a pre-conference short course at the Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference 9:00 a.m. to noon, Tuesday, February 27 at the Moscone North Convention Center in San Francisco. The presentations will address circulating tumor cells (CTCs) as a biomarker in cancer drug research and development.
